Novartis Investigative Site

Amersfroort 3818 ES

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Melanoma

Studies at this site

• A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma — Stopped early
• A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. — Completed